Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Teplizumab For Diabetes Episode 315 – Real Life Pharmacology Podcast

02.22.2024 - By Eric Christianson, PharmD; Pharmacology Expert and Clinical PharmacistPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Teplizumab is a relatively new agent that helps delay the progression of type 1 diabetes. It slows the rate of beta-cell destruction in the pancreas.

Teplizumab is associated with cytokine release syndrome which can result in flu-like symptoms of fever, aches, and headache.

Cytokine release syndrome due to teplizumab can be reduced by using appropriate pretreatment medications. Those medications can include analgesics, antihistamines, and/or antiemetics.

Teplizumab is associated with suppressing the immune system so it is ideal to get vaccinations completed before using this medication. I go over the specific recommendations in the podcast episode.

More episodes from Real Life Pharmacology - Pharmacology Education for Health Care Professionals